Jaguar Health (JAGX) Cash from Operations (2014 - 2026)

Jaguar Health (JAGX) has 13 years of Cash from Operations data on file, last reported at 8830000.0 in Q1 2026.

• On a quarterly basis, Cash from Operations rose 220.73% year-over-year to 8830000.0 in Q1 2026; TTM through Mar 2026 was 7542000.0, a 74.56% increase from a year earlier, with the FY2025 full-year figure at 23686000.0, up 19.39% from the prior year.
• Cash from Operations for Q1 2026 stood at 8830000.0, up from 5488000.0 in the prior quarter.
• Over the last five years, Cash from Operations for JAGX reached as high as 8830000.0 in Q1 2026 and fell as low as 10457000.0 in Q2 2022.
• Historically, Cash from Operations has averaged 6505058.82 across 5 years, with a median of 7314000.0 in 2025.
• Across the five-year window, Cash from Operations slipped 29.24% in 2023 and soared 220.73% in 2026, its largest moves.
• Year by year, Cash from Operations stood at 6423000.0 in 2022, then retreated by 16.0% to 7451000.0 in 2023, then declined by 5.03% to 7826000.0 in 2024, then climbed by 29.87% to 5488000.0 in 2025, then surged by 260.9% to 8830000.0 in 2026.
• Per Business Quant data, the three most recent Cash from Operations figures were 8830000.0 in Q1 2026, 5488000.0 in Q4 2025, and 4689000.0 in Q3 2025.